Bentham is offering subject-based scholarly content collections which are tailored to meet specific research needs. Researchers can access related articles from current and back volumes by purchasing access to these collections. Subscribers will also have access to new articles as soon as they are published and added to these collections. With new articles being added to these collections on a daily basis, the collections serve as an ideal tool to keep researchers updated with new developments in the respective fields.
Journal: Current Cancer Therapy Reviews Volume: 21 Page: 10-22 Author(s): Mehdi Pezeshgi Modarres, Mohammad Amin Habibi, Mohammad Reza Pashaei, Yousef Mohammadpour, Kimia Jazi and Sajjad Ahmadpour*
Journal: Letters in Drug Design & Discovery Volume: 21 Page: 2875-2890 Author(s): Mohadeseh Poudineh, Samaneh Mollazadeh, Shima Mehrabadi, Majid Khazaei, Seyed Mahdi Hassanian and Amir Avan*
Journal: Letters in Drug Design & Discovery Volume: 21 Page: 2838-2852 Author(s): Girish Chandra Arya*, Rajiv Sharma and Shefali Mehla
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry Volume: 22 Page: 308-318 Author(s): Pankaj Kumar Tripathi and Chakresh Kumar Jain*
Journal: Current Stem Cell Research & Therapy Volume: 19 Page: 1293-1302 Author(s): Xieyin Sun, Zhaoyi Lin, Nuo Xu, Yinqi Chen, Saiyan Bian and Wenjie Zheng*
Journal: Current Stem Cell Research & Therapy Volume: 19 Page: 1312-1320 Author(s): Mudassir Khan, Mashal Naeem, Sana Aftab Chaudary, Affan Ahmed and Aftab Ahmed*
Journal: Current Stem Cell Research & Therapy Volume: 19 Page: 1303-1311 Author(s): Hengameh Dortaj*, Negar Azarpira* and Sara Pakbaz
Journal: Current Stem Cell Research & Therapy Volume: 19 Page: 1461-1471 Author(s): Hongru Ruan, Hui Shi, Wenkang Luan and Sida Pan*
Journal: Current Cancer Drug Targets Volume: 24 Page: 1286-1297 Author(s): Mehran Pashirzad and Amirhossein Sahebkar*
Journal: Current Cancer Drug Targets Volume: 24 Page: 1235-1249 Author(s): Fabiao Zhang, Binfeng Wang, Wenlong Zhang, Yongfu Xu, Caiming Zhang* and Xiangyang Xue*